Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.9100
-0.0900 (-9.00%)
At close: May 12, 2026, 4:00 PM EDT
0.9300
+0.0200 (2.20%)
After-hours: May 12, 2026, 5:58 PM EDT
Humacyte Stock Forecast
Stock Price Forecast
The 8 analysts that cover Humacyte stock have a consensus rating of "Strong Buy" and an average price target of $6.19, which forecasts a 580.22% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $25.
Price Target: $6.19 (+580.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,647.25% | Apr 28, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +229.67% | Apr 28, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,647.25% | Apr 24, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,647.25% | Apr 21, 2026 |
| Barclays | Barclays | Buy Maintains $3.5 → $1.5 | Buy | Maintains | $3.5 → $1.5 | +64.84% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
11.09M
from 2.04M
Increased by 444.16%
Revenue Next Year
38.64M
from 11.09M
Increased by 248.39%
EPS This Year
-0.44
from -0.26
EPS Next Year
-0.29
from -0.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 15.9M | 51.7M | ||||||
| Avg | 11.1M | 38.6M | ||||||
| Low | 6.9M | 26.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 679.5% | 365.8% | ||||||
| Avg | 444.2% | 248.4% | ||||||
| Low | 236.6% | 134.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.36 | -0.16 | ||||||
| Avg | -0.44 | -0.29 | ||||||
| Low | -0.54 | -0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.